Morgan Stanley reiterates Overweight rating on Huntington Bancshares stock

Morgan Stanley reiterated an Overweight rating and $19 price target on Huntington Bancshares (HBAN), citing the strategic value of its $1.9 billion all-stock Veritex acquisition. This deal is projected to expand HBAN's presence in key Texas growth markets, adding $13 billion in assets and delivering EPS accretion of 2% by 2026 and 4% by 2027. Despite Veritex's higher criticized assets, Morgan Stanley views credit risk as low, aligning with other positive analyst coverage from Wolfe Research and Jefferies, signaling a strong outlook for HBAN's growth and financial performance.

Analysis

Huntington Bancshares (HBAN) is receiving strong positive sentiment from multiple research firms, primarily driven by its strategic all-stock acquisition of Veritex Holdings (VBTX) for $1.9 billion. Morgan Stanley reiterates its Overweight rating with a $19 price target, viewing the deal as a key driver for expanding HBAN's scale in high-growth Texas markets, adding approximately $13 billion in assets and $11 billion in deposits. The acquisition is projected to deliver modest but clear financial benefits, with an estimated 2% accretion to earnings per share in 2026, increasing to 4% by 2027. This positive outlook is reinforced by Wolfe Research, which upgraded HBAN to Outperform on expectations of net interest margin expansion, and Jefferies, which initiated coverage with a Buy rating and a $20 target, citing strong loan and deposit growth relative to peers. While Veritex brings higher criticized assets and commercial real estate exposure, Morgan Stanley assesses the associated credit risk as low, mitigated by recent declines in those assets and a 1.5% loan mark. The transaction, expected to close in Q4 2025, represents a clear strategic move to enhance growth and profitability through defined synergies like reducing deposit costs and enhancing fee income.

Key Decisions for Investors

• Given the strong consensus from Morgan Stanley, Wolfe Research, and Jefferies, with price targets of $19 and $20 significantly above the current price, investors should consider the stock's appreciation potential driven by its strategic M&A activity.
• Monitor the execution of the Veritex acquisition post-closing in Q4 2025, focusing on key synergy metrics such as reduced deposit costs and fee income growth, as these are critical to achieving the projected 2-4% EPS accretion.
• While analysts deem the credit risk manageable, it is prudent to track Huntington's reported levels of criticized assets and commercial real estate exposure following the integration of Veritex, as this remains a key risk factor.